These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36698527)

  • 1. Vaccine-induced immune thrombotic thrombocytopenia (VITT) after SARS-CoV-2 vaccination: Two cases from Germany with unusual presentation.
    Edmonds R; Schönborn L; Habben S; Paparoupa M; Greinacher A; Schuppert F
    Clin Case Rep; 2023 Jan; 11(1):e6883. PubMed ID: 36698527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.
    van de Munckhof A; Lindgren E; Kleinig TJ; Field TS; Cordonnier C; Krzywicka K; Poli S; Sánchez van Kammen M; Borhani-Haghighi A; Lemmens R; Scutelnic A; Ciccone A; Gattringer T; Wittstock M; Dizonno V; Devroye A; Elkady A; Günther A; Cervera A; Mengel A; Chew BLA; Buck B; Zanferrari C; Garcia-Esperon C; Jacobi C; Soriano C; Michalski D; Zamani Z; Blacquiere D; Johansson E; Cuadrado-Godia E; Vuillier F; Bode FJ; Caparros F; Maier F; Tsivgoulis G; Katzberg HD; Duan J; Burrow J; Pelz J; Mbroh J; Oen J; Schouten J; Zimmermann J; Ng K; Garambois K; Petruzzellis M; Carvalho Dias M; Ghiasian M; Romoli M; Miranda M; Wronski M; Skjelland M; Almasi-Dooghaee M; Cuisenier P; Murphy S; Timsit S; Coutts SB; Schönenberger S; Nagel S; Hiltunen S; Chatterton S; Cox T; Bartsch T; Shaygannejad V; Mirzaasgari Z; Middeldorp S; Levi MM; Kremer Hovinga JA; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; Aguiar de Sousa D; Ferro JM; Coutinho JM;
    Stroke; 2022 Oct; 53(10):3206-3210. PubMed ID: 36082668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations.
    Lavin M; Elder PT; O'Keeffe D; Enright H; Ryan E; Kelly A; El Hassadi E; McNicholl FP; Benson G; Le GN; Byrne M; Ryan K; O'Connell NM; O'Donnell JS
    Br J Haematol; 2021 Oct; 195(1):76-84. PubMed ID: 34159588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
    van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
    Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes.
    Allas GDO; Arizala JDR; Manalo RVM
    Hematol Rep; 2022 Dec; 14(4):358-372. PubMed ID: 36547234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
    Liu Y; Shao Z; Wang H
    Thromb Res; 2022 Jan; 209():75-79. PubMed ID: 34894531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway.
    Salih F; Kohler S; Schönborn L; Thiele T; Greinacher A; Endres M
    Eur Heart J Open; 2022 May; 2(3):oeac036. PubMed ID: 35919343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis and thrombocytopenia after HPV vaccination.
    Johansen S; Laegreid IJ; Ernstsen SL; Azrakhsh NA; Kittang AO; Lindås R; Gjertsen BT; Vetti N; Mørtberg TV; Sørvoll IH; Holme PA; Ahlen MT; Reikvam H
    J Thromb Haemost; 2022 Mar; 20(3):700-704. PubMed ID: 34817130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer.
    Connors JM; Iba T
    Thromb Res; 2022 May; 213 Suppl 1():S77-S83. PubMed ID: 36210565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Hwang J; Han YJ; Yon DK; Lee SW; Kim BK; Lee SB; Lee MH; Park SH; Koyanagi A; Jacob L; Tizaoui K; Kim SU; Shin JI; Smith L
    Int J Infect Dis; 2022 Mar; 116():114-121. PubMed ID: 34958931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series.
    Mendes-de-Almeida DP; ; Mouta Nunes de Oliveira P; Bertollo Gomes Porto V; Saraiva Pedro R; Takey PRG; Lignani LK; Vitiello Teixeira G; Pereira TDS; Abreu DL; Xavier JR; Castro TDM; Melo de Amorim Filho L; Sousa Maia ML
    Res Pract Thromb Haemost; 2023 Nov; 7(8):102243. PubMed ID: 38193064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.
    Greinacher A; Langer F; Makris M; Pai M; Pavord S; Tran H; Warkentin TE
    J Thromb Haemost; 2022 Jan; 20(1):149-156. PubMed ID: 34693641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.